Cosmo Bio Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
504.00
369.00
653.00
790.00
1,099.00
1,008.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
18.00
-56.00
162.00
-367.00
-217.00
-31.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
595.00
241.00
744.00
306.00
648.00
803.00
Cash Flow from Investing Activities
43.00
-217.00
-766.00
-313.00
-145.00
42.00
Cash Flow from Financing Activities
-283.00
-479.00
-201.00
-236.00
-420.00
-97.00
Net Cash Inflow / Outflow
354.00
-433.00
-210.00
-219.00
95.00
743.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
22.00
13.00
24.00
12.00
-5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cosmo Bio Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
504
588
-84.00
-14.29%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
18
461
-443.00
-96.10%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
595
1472
-877.00
-59.58%
Cash Flow from Investing Activities
43
-229
272.00
118.78%
Cash Flow from Financing Activities
-283
-1337
1,054.00
78.83%
Net Cash Inflow / Outflow
354
-97
451.00
464.95%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1
-3
2.00
66.67%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 146.89% vs -67.61% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
595.00
241.00
146.89%






